BARBERA, MARIA CHIARA
BARBERA, MARIA CHIARA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses
2025 Barbera, M; Guarrera, L; Re Cecconi, A; Cassanmagnago, G; Vallerga, A; Lunardi, M; Checchi, F; Di Rito, L; Romeo, M; Mapelli, S; Schoser, B; Generozov, E; Semenova, E; Kulemin, N; Kanygina, A; Sultanov, R; Jansen, R; de Geus, E; Penninx, B; van Dongen, J; Craparotta, I; Piccirillo, R; Ahmetov, I; Bolis, M
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma
2025 Petrella, S; Colombo, M; Marabese, M; Grasselli, C; Panfili, A; Chiappa, M; Sancisi, V; Craparotta, I; Barbera, M; Cassanmagnago, G; Bolis, M; Damia, G
Reactivation of miR-29 Mitigates Epigenetic Deregulation and Tumor Progression in Advanced Prostate Cancer
2025 Vallerga, A; Craparotta, I; Barbera, M; Andrea Cassanmagnago, G; Grasselli, C; Panfili, A; Guarrera, L; Bolis, M
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
2025 Varone, E; Retini, M; Cherubini, A; Chernorudskiy, A; Marrazza, A; Guidarelli, A; Cagnotto, A; Beeg, M; Gobbi, M; Fumagalli, S; Bolis, M; Guarrera, L; Barbera, M; Grasselli, C; Bleve, A; Generali, D; Milani, M; Mari, M; Salmona, M; Piersanti, G; Bottegoni, G; Broggini, M; Janssen-Heininger, Y; Cho, J; Cantoni, O; Zito, E
Abstract 4685: The identification of new therapeutic targets in mucinous ovarian carcinoma
2024 Petrella, S; Colombo, M; Marabese, M; Grasselli, C; Panfili, A; Craparotta, I; Barbera, M; Cassanmagnago, G; Bolis, M; Damia, G
Exploring tumor heterogeneity at the basis of cisplatin resistance in ovarian cancer using single cell RNA sequencing
2024 Perotti, L; Capellini, E; Guarrera, L; Craparotta, I; Barbera, M; Grasselli, C; Bolis, M; Ricci, F
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy
2024 Riva, A; Sahin, E; Volpedo, G; Petretto, A; Lavarello, C; Di Sapia, R; Barbarossa, D; Zaniani, N; Craparotta, I; Barbera, M; Sezerman, U; Vezzani, A; Striano, P; Ravizza, T
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
2024 Chiappa, M; Decio, A; Guarrera, L; Mengoli, I; Karki, A; Yemane, D; Ghilardi, C; Scanziani, E; Canesi, S; Barbera, M; Craparotta, I; Bolis, M; Fruscio, R; Grasselli, C; Ceruti, T; Zucchetti, M; Patterson, J; Lu, R; Yaffe, M; Ridinger, M; Damia, G; Guffanti, F
Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience
2022 Varone, E; Decio, A; Barbera, M; Bolis, M; Di Rito, L; Pisati, F; Giavazzi, R; Zito, E
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models
2022 Meroni, M; Craparotta, I; Mannarino, L; Barbera, M; Bello, E; Cavallaro, U; Bertalot, G; Lorenzo Renne, S; D’Incalci, M; Frapolli, R